13F-HR filed by Avoro Capital Advisors LLC
Avoro Capital Advisors LLC filed this 13F-HR for the quarter ended 2018-12-31, filed 2019-02-14, with 35 holding rows worth $1,672,821,000.
- Accession
- 0001144204-19-007742
- Filer
- CIK 1633313
- Filed
- 2019-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2018
A holdings report, 35 entries on the cover page, a total value of $1,672,821,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,672,821,000 with VALUE read as thousands by filing date, 13F file number 028-16573. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IMMUNOMEDICS INC | 452907108 | COM | 17,714,461 | $252,785,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 4,798,101 | $203,535,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 1,275,000 | $139,141,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 1,980,000 | $124,047,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 1,360,000 | $115,804,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 10,125,000 | $96,998,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 10,261,039 | $90,810,000 | thousands by filing date | |
| HORIZON PHARMA PLC | G4617B105 | SHS | 4,350,000 | $84,999,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 860,000 | $82,620,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 5,575,000 | $75,876,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 1,975,000 | $72,009,000 | thousands by filing date | |
| LOXO ONCOLOGY INC | 548862101 | COM | 325,000 | $45,523,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 1,750,000 | $41,265,000 | thousands by filing date | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 1,128,584 | $27,753,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 225,000 | $25,362,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 1,000,000 | $22,620,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 4,750,000 | $19,475,000 | thousands by filing date | |
| INTEC PHARMA LTD JERUSALEM | M53644106 | SHS | 2,500,000 | $18,850,000 | thousands by filing date | |
| BIODELIVERY SCIENCES INTL IN | 09060J106 | COM | 4,725,000 | $17,483,000 | thousands by filing date | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 400,000 | $17,208,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 2,400,000 | $15,144,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 350,000 | $14,368,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 380,000 | $13,042,000 | thousands by filing date | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 475,000 | $13,025,000 | thousands by filing date | |
| TELIGENT INC NEW | 87960W104 | COM | 5,300,000 | $7,261,000 | thousands by filing date | |
| FENNEC PHARMACEUTICALS INC | 31447P100 | COMMON STOCK | 1,105,999 | $7,056,000 | thousands by filing date | |
| KODIAK SCIENCES INC | 50015M109 | COM | 902,200 | $6,406,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 310,000 | $6,305,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 6,240,000 | $4,481,000 | thousands by filing date | |
| PROTEOSTASIS THERAPEUTICS IN | 74373B109 | COM | 1,300,000 | $4,212,000 | thousands by filing date | |
| ACER THERAPEUTICS INC | 00444P108 | CMN | 150,000 | $3,018,000 | thousands by filing date | |
| PERNIX THERAPEUTICS HLDGS IN | 71426VAK4 | DBCV 4.250 4/0 | 6,000,000 | $2,545,000 | thousands by filing date | principal |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 500,000 | $1,440,000 | thousands by filing date | call |
| OUTLOOK THERAPEUTICS INC | 69012T107 | COM | 680,000 | $340,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 50,000 | $15,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-19-007742 | this filing | 2019-02-14 | acceptance time not in the bulk data set |